IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort

IntroductionMultisystem inflammatory syndrome in children (MIS-C) is a severe acute inflammatory reaction to SARS-CoV-2 infection in children. There is a lack of data describing differential expression of immune genes in MIS-C compared to healthy children or those with other inflammatory conditions...

Full description

Bibliographic Details
Main Authors: Timothy F. Spracklen, Simon C. Mendelsohn, Claire Butters, Heidi Facey-Thomas, Raphaella Stander, Debbie Abrahams, Mzwandile Erasmus, Richard Baguma, Jonathan Day, Christiaan Scott, Liesl J. Zühlke, George Kassiotis, Thomas J. Scriba, Kate Webb
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.992022/full
_version_ 1818067261123985408
author Timothy F. Spracklen
Timothy F. Spracklen
Simon C. Mendelsohn
Claire Butters
Claire Butters
Heidi Facey-Thomas
Raphaella Stander
Debbie Abrahams
Mzwandile Erasmus
Richard Baguma
Jonathan Day
Christiaan Scott
Liesl J. Zühlke
Liesl J. Zühlke
Liesl J. Zühlke
George Kassiotis
George Kassiotis
Thomas J. Scriba
Kate Webb
Kate Webb
author_facet Timothy F. Spracklen
Timothy F. Spracklen
Simon C. Mendelsohn
Claire Butters
Claire Butters
Heidi Facey-Thomas
Raphaella Stander
Debbie Abrahams
Mzwandile Erasmus
Richard Baguma
Jonathan Day
Christiaan Scott
Liesl J. Zühlke
Liesl J. Zühlke
Liesl J. Zühlke
George Kassiotis
George Kassiotis
Thomas J. Scriba
Kate Webb
Kate Webb
author_sort Timothy F. Spracklen
collection DOAJ
description IntroductionMultisystem inflammatory syndrome in children (MIS-C) is a severe acute inflammatory reaction to SARS-CoV-2 infection in children. There is a lack of data describing differential expression of immune genes in MIS-C compared to healthy children or those with other inflammatory conditions and how expression changes over time. In this study, we investigated expression of immune-related genes in South African MIS-C patients and controls.MethodsThe cohort included 30 pre-treatment MIS-C cases and 54 healthy non-inflammatory paediatric controls. Other controls included 34 patients with juvenile systemic lupus erythematosus, Kawasaki disease or other inflammatory conditions. Longitudinal post-treatment MIS-C specimens were available at various timepoints. Expression of 80 immune-related genes was determined by real-time quantitative PCR.ResultsA total of 29 differentially expressed genes were identified in pre-treatment MIS-C compared to healthy controls. Up-regulated genes were found to be overrepresented in innate immune pathways including interleukin-1 processing and pyroptosis. Post-treatment follow-up data were available for up to 1,200 hours after first treatment. All down-regulated genes and 17/18 up-regulated genes resolved to normal levels in the timeframe, and all patients clinically recovered. When comparing MIS-C to other febrile conditions, only IL27 expression could differentiate these two groups with high sensitivity and specificity.ConclusionsThese data indicate a unique 29-gene signature of MIS-C in South African children. The up-regulation of interleukin-1 and pyroptosis pathway genes highlights the role of the innate immune system in MIS-C. IL-27 is a potent anti-inflammatory and antiviral cytokine that may distinguish MIS-C from other conditions in our setting.
first_indexed 2024-12-10T15:20:52Z
format Article
id doaj.art-d7ac4d8646a54854b4af3a86f551f2e7
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-10T15:20:52Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-d7ac4d8646a54854b4af3a86f551f2e72022-12-22T01:43:42ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.992022992022IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohortTimothy F. Spracklen0Timothy F. Spracklen1Simon C. Mendelsohn2Claire Butters3Claire Butters4Heidi Facey-Thomas5Raphaella Stander6Debbie Abrahams7Mzwandile Erasmus8Richard Baguma9Jonathan Day10Christiaan Scott11Liesl J. Zühlke12Liesl J. Zühlke13Liesl J. Zühlke14George Kassiotis15George Kassiotis16Thomas J. Scriba17Kate Webb18Kate Webb19Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaCape Heart Institute, University of Cape Town, Cape Town, South AfricaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaDivision of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaCape Heart Institute, University of Cape Town, Cape Town, South AfricaSouth African Medical Research Council, Cape Town, South AfricaRetroviral Immunology Laboratory, The Francis Crick Institute, London, United KingdomDepartment of Infectious Disease, St Mary’s Hospital, Imperial College, London, United KingdomSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics and Child Health, University of Cape Town, Cape Town, South AfricaCrick African Network, The Francis Crick Institute, London, United KingdomIntroductionMultisystem inflammatory syndrome in children (MIS-C) is a severe acute inflammatory reaction to SARS-CoV-2 infection in children. There is a lack of data describing differential expression of immune genes in MIS-C compared to healthy children or those with other inflammatory conditions and how expression changes over time. In this study, we investigated expression of immune-related genes in South African MIS-C patients and controls.MethodsThe cohort included 30 pre-treatment MIS-C cases and 54 healthy non-inflammatory paediatric controls. Other controls included 34 patients with juvenile systemic lupus erythematosus, Kawasaki disease or other inflammatory conditions. Longitudinal post-treatment MIS-C specimens were available at various timepoints. Expression of 80 immune-related genes was determined by real-time quantitative PCR.ResultsA total of 29 differentially expressed genes were identified in pre-treatment MIS-C compared to healthy controls. Up-regulated genes were found to be overrepresented in innate immune pathways including interleukin-1 processing and pyroptosis. Post-treatment follow-up data were available for up to 1,200 hours after first treatment. All down-regulated genes and 17/18 up-regulated genes resolved to normal levels in the timeframe, and all patients clinically recovered. When comparing MIS-C to other febrile conditions, only IL27 expression could differentiate these two groups with high sensitivity and specificity.ConclusionsThese data indicate a unique 29-gene signature of MIS-C in South African children. The up-regulation of interleukin-1 and pyroptosis pathway genes highlights the role of the innate immune system in MIS-C. IL-27 is a potent anti-inflammatory and antiviral cytokine that may distinguish MIS-C from other conditions in our setting.https://www.frontiersin.org/articles/10.3389/fimmu.2022.992022/fullCOVID-19multisystem inflammatory syndromechildrenSouth AfricaSARS-CoV-2
spellingShingle Timothy F. Spracklen
Timothy F. Spracklen
Simon C. Mendelsohn
Claire Butters
Claire Butters
Heidi Facey-Thomas
Raphaella Stander
Debbie Abrahams
Mzwandile Erasmus
Richard Baguma
Jonathan Day
Christiaan Scott
Liesl J. Zühlke
Liesl J. Zühlke
Liesl J. Zühlke
George Kassiotis
George Kassiotis
Thomas J. Scriba
Kate Webb
Kate Webb
IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort
Frontiers in Immunology
COVID-19
multisystem inflammatory syndrome
children
South Africa
SARS-CoV-2
title IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort
title_full IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort
title_fullStr IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort
title_full_unstemmed IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort
title_short IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort
title_sort il27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a south african cohort
topic COVID-19
multisystem inflammatory syndrome
children
South Africa
SARS-CoV-2
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.992022/full
work_keys_str_mv AT timothyfspracklen il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT timothyfspracklen il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT simoncmendelsohn il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT clairebutters il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT clairebutters il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT heidifaceythomas il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT raphaellastander il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT debbieabrahams il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT mzwandileerasmus il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT richardbaguma il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT jonathanday il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT christiaanscott il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT liesljzuhlke il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT liesljzuhlke il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT liesljzuhlke il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT georgekassiotis il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT georgekassiotis il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT thomasjscriba il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT katewebb il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort
AT katewebb il27geneexpressiondistinguishesmultisysteminflammatorysyndromeinchildrenfromfebrileillnessinasouthafricancohort